Lista de obras - Vincenzo Marotta - Dominio Público Uruguay

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.

artículo científico publicado en 2012

Application of molecular biology of differentiated thyroid cancer for clinical prognostication

artículo científico publicado en 2016

Are RET/PTC rearrangements in benign thyroid nodules of biological significance?

artículo científico publicado en 2010

Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases

artículo científico publicado en 2013

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

artículo científico publicado en 2012

BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma

artículo científico

BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present

artículo científico publicado en 2013

BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.

artículo científico publicado en 2013

Benign thyroid nodules with RAS mutation grow faster.

artículo científico publicado en 2015

Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame

artículo científico publicado en 2017

Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas

artículo científico publicado en 2014

Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge.

artículo científico publicado en 2015

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings

artículo científico publicado en 2007

Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib

artículo científico publicado en 2017

Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.

artículo científico publicado en 2014

Fathoming the link between anthropogenic chemical contamination and thyroid cancer

artículo científico publicado en 2020

Fibrous Variant of Hashimoto's Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology

artículo científico publicado en 2013

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.

artículo científico publicado en 2016

Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome

artículo científico publicado en 2018

Growing thyroid nodules with benign histology and RET rearrangement.

artículo científico publicado en 2010

Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.

artículo científico

Hepatic arterial embolization in patients with neuroendocrine tumors

artículo científico publicado en 2014

High growth rate of benign thyroid nodules bearing RET/PTC rearrangements

artículo científico publicado en 2011

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules

artículo científico publicado en 2018

Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.

artículo científico publicado en 2013

Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours

scientific article published on 19 February 2014

Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells.

artículo científico publicado en 2012

Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells.

artículo científico publicado en 2012

Limitations of Chromogranin A in clinical practice

artículo científico publicado en 2012

Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication

artículo científico publicado en 2014

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

artículo científico publicado en 2016

Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.

artículo científico publicado en 2010

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

artículo científico publicado en 2015

RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.

artículo científico publicado en 2011

Radioiodide induces apoptosis in human thyroid tissue in culture.

artículo científico publicado en 2013

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

artículo científico publicado en 2014

Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET.

artículo científico publicado en 2013

Targeted therapy with kinase inhibitors in aggressive endocrine tumors

artículo científico

The evolving field of kinase inhibitors in thyroid cancer

artículo científico

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.

artículo científico publicado en 2011

Thyroid diseases in elderly.

artículo científico

Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study

artículo científico publicado en 2012

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

scientific article published on 03 January 2014

Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill?

artículo científico publicado en 2017

Lista de obras de Vincenzo Marotta

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.

Application of molecular biology of differentiated thyroid cancer for clinical prognostication

Are RET/PTC rearrangements in benign thyroid nodules of biological significance?

Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma

BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present

BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.

Benign thyroid nodules with RAS mutation grow faster.

Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame

Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas

Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge.

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings

Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib

Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.

Fathoming the link between anthropogenic chemical contamination and thyroid cancer

Fibrous Variant of Hashimoto's Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.

Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome

Growing thyroid nodules with benign histology and RET rearrangement.

Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.

Hepatic arterial embolization in patients with neuroendocrine tumors

High growth rate of benign thyroid nodules bearing RET/PTC rearrangements

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules

Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.

Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours

Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells.

Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells.

Limitations of Chromogranin A in clinical practice

Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.

Radioiodide induces apoptosis in human thyroid tissue in culture.

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib

Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET.

Targeted therapy with kinase inhibitors in aggressive endocrine tumors

The evolving field of kinase inhibitors in thyroid cancer

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.

Thyroid diseases in elderly.

Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study

Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill?